- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Following the Patient's Lead
The old adage “the doctor knows best” affirms patients’ trust in a physician’s impartial and expert opinion in matters of health, but can physicians continue to be solo managers of patient care? At Newton Medical Center in Newton, NJ, Renee C. Comizio, M.D., M.S., board-certified plastic and reconstructive surgeon, is providing an avenue for breast cancer patients to take an active role in defining their own treatments through shared decision-making.
The shared decision-making program is founded in the belief that each patient has the right to choose the most appropriate medical treatment for his or her life and medical concern. An informed medical decision ensures safety and personalized care while reducing the chance of treatment being tailored to the physician’s preference rather than the patient’s needs and desires.
Read more at: http://www.mdnews.com/news/2011_12/05782_novdec2011_following-the-patient
Source: MDNews.com
Legal Navigation Services Key to Addressing Disparities in Cancer Care
July 31st 2025A significant number of patients with cancer, caregivers, and health care professionals face significant disparities in legal issues, with the most common needs revolving around health insurance, finances, employment, and disability insurance.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
It Take a Village in Cancer Care: A Q&A With David Nguyen, MD
July 23rd 2025David Nguyen, MD, medical oncologist with Tufts Medicine and Lowell General Hospital, discusses the evolving landscape of advanced cancer treatments like chimeric antigen receptor T-cell therapy and bispecific antibodies
Read More
